Literature DB >> 2665776

The role of lymphokines in common variable hypogammaglobulinemia.

G P Spickett, J Farrant.   

Abstract

Common variable (acquired) hypogammaglobulinemia (CVH) is a rare primary immunodeficiency disease of great interest as an immunological model of defects in antibody production. In this article, Gavin Spickett and John Farrant discuss evidence of abnormalities in lymphokine production and responses in the generation of the functional failure. It is not yet clear whether the B cell is intrinsically abnormal or lacks appropriate signals, but the block appears to occur in the differentiation phase of B cells, since membrane (but not secreted) IgG is made. Some T-cell defects also occur in this disease. The cause of CVH is unknown, although a viral aetiology has been suggested. Better understanding of lymphokine networks may allow the provision of specific signals to overcome the block in antibody production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665776     DOI: 10.1016/0167-5699(89)90323-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  7 in total

1.  LFA-1-dependent OKT3-driven T cell clusters in common variable immunodeficiency.

Authors:  W Rudnicka; N English; J Farrant; M E North; A E Bryant; A J Edwards; A Stackpoole; A D Webster; B M Balfour
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

2.  Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease.

Authors:  Shradha Agarwal; Paul Smereka; Noam Harpaz; Charlotte Cunningham-Rundles; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

3.  Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

Authors:  J A Rump; D Jakschiess; U Walker; M Schlesier; P von Wussow; H H Peter
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

4.  Autoimmune manifestations in common variable immunodeficiency.

Authors:  Stavroula Giannouli; Dimitra Anagnostou; Fotini Soliotis; Michalis Voulgarelis
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

5.  A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID).

Authors:  J A Rump; A Jahreis; M Schlesier; S Stecher; H H Peter
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

6.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Hypogammaglobulinemia in McArdle myopathy (glycogenosis type V).

Authors:  M E Westarp; V Schreiner; H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.